Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-23

Clinical Trial Update: Gluma Compared With Bonding Agent for Post-operative Sensitivity Following Composite Restorations [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial compares Gluma desensitizer with a bonding agent to reduce post-operative sensitivity after composite restorations, spanning Phase 2 and Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gluma Desensitizer (glutaraldehyde/HEMA desensitizer)

Snippet

Sponsor: Beenish Hassan | Conditions: Post-operative Sensitivity, Dentin Hypersensitivity | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING